🔎 Trials Near Me

Home › Coronary Artery Disease › Pennsylvania › Pittsburgh

Coronary Artery Disease clinical trials in Pittsburgh, PA

6 studies for Coronary Artery Disease are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Product Surveillance Registry

RecruitingObservational study
  • Pittsburgh, Pittsburgh
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

Randomization of Single vs Multiple Arterial Grafts

Recruiting
  • Allegheny General Hospital (Cardiovascular Institute), Pittsburgh
Ages 18 to 70 · All sexes · Updated Aug 20, 2026 · NCT03217006

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

RecruitingObservational study
  • University of Pittsburgh Medical Center Presbyterian, Pittsburgh
All ages · All sexes · Updated Aug 19, 2026 · NCT02061436

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Recruiting
  • Allegheny General Hospital, Pittsburgh
Ages 18 and older · Women · Updated Apr 1, 2026 · NCT04124120

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

RecruitingPhase 2/3
  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT04982419

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Recruiting
  • University of Pittsburgh Medical center (UPMC), Pittsburgh
Ages 18 to 80 · All sexes · Updated Sep 11, 2025 · NCT06271590

About Coronary Artery Disease

Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.

More about Coronary Artery Disease on MedlinePlus

Coronary Artery Disease trials in other cities

Other studies in Pittsburgh

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.